Tamoxifen and dental implant healing
Dental implants in patients on tamoxifen alone generally have success rates close to non-cancer patients. Tamoxifen by itself does not strongly impair osseointegration. The conversation gets more complex when patients are also on bisphosphonates or denosumab for bone protection (common in breast cancer regimens), or when the timeline includes a future transition to aromatase inhibitors. Coordination with your oncology team matters more than the medication name on its own.
Dental implant success depends on osseointegration: bone growing into the surface of the titanium implant. The process requires active bone remodeling, which is affected by hormonal status. Tamoxifen has variable effects on bone depending on menopausal status: it acts like a partial estrogen in bone for postmenopausal women (mildly bone-protective) and has more complex effects in premenopausal women.
Studies of dental implants in tamoxifen patients show survival rates comparable to non-cancer patients, particularly for postmenopausal users where the bone effect leans protective. Premenopausal patients on tamoxifen may have slightly different bone remodeling characteristics, but published outcomes are still generally favorable.
The bigger questions for implant patients on tamoxifen are usually downstream: Are you also on a bisphosphonate (Zometa, Boniva, Aredia)? Are you on denosumab (Xgeva)? Have you had head and neck radiation? Each of these changes the planning more than tamoxifen does. Treatment is best coordinated with your oncology team, especially in the first few years after diagnosis.
- Tell your dentist your full breast cancer treatment history, including past chemotherapy, radiation, and current medications.
- Confirm with your oncology team that your cancer is well-controlled and that elective implant surgery fits your treatment timeline.
- Ask whether you are on or scheduled for any anti-resorptive medications (bisphosphonates, denosumab). These change the conversation substantially.
- If you have had head or neck radiation, this raises a separate concern (osteoradionecrosis) that may take precedence over the tamoxifen question.
- Optimize oral hygiene before surgery. Lower oral bacterial load reduces infection risk during healing.
- Plan for routine follow-up at six months and one year post-implant to confirm integration is on track.
- Pain that gets worse after day three instead of better.
- Swelling that increases past day three or that comes with fever.
- Pus, foul taste, or a bad odor from the surgical site.
- The implant feels loose or wobbly at any point.
- Exposed bone or non-healing tissue around the implant site (this matters more if you are also on a bisphosphonate).
General guidance is a starting point. Your specific dental plan depends on your medical history, your other medications, and what your mouth looks like in person. Schedule a consultation and we’ll walk through it.
Reviewed by Dr. Isaac Sun, DDS.
This page is general information, not medical advice. Do not start, stop, or change any medication based on what you read here. Talk to your prescribing physician and your dentist about your specific situation.